Are elevated vancomycin serum trough concentrations achievedwithin the first 7 days of therapy associatedwith acute kidney injury in children?

Journal of the Pediatric Infectious Diseases Society

Volumn 3, Issue 2, 2014, Pages 127-131

  Knoderer, Chad A ^a   Nichols, Kristen R ^a,b,c   Lyon, Kelsey C ^d   Veverka, Megan M ^e   Wilson, Amy C ^c  

^a BUTLER UNIVERSITY   (United States)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Spectrum Health ^*  (United States)

^e SPECTRUM HEALTH   (United States)

Author keywords

Acute kidney injury; Nephrotoxicity; Pediatric; Vancomycin

Indexed keywords

CREATININE; MEROPENEM; VANCOMYCIN; ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN B DEOXYCHOLATE; CALCINEURIN INHIBITOR; CONTRAST MEDIUM; CYCLOSPORIN; NONSTEROID ANTIINFLAMMATORY AGENT; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADOLESCENT; ARTICLE; CHILD; CLINICAL EVALUATION; COHORT ANALYSIS; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; FEMALE; HUMAN; ICD-9; INCIDENCE; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; NEWBORN; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; DRUG BLOOD LEVEL; HOSPITAL ADMISSION; MEDICAL RECORD REVIEW;

EID: 84921465980     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pit076     Document Type: Article

References (14)

1. Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 2008; 23:2159-73
2. Frymoyer A, Hersh AL, Benet LZ, et al. Current recommended dosing of vancomycin for children with invasive methicillinresistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 2009; 28:398-402
3. Rybak MJ, Lomaestro, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66:82-98
4. Frymoyer A, Guglielmo BJ, Wilson SD, et al. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Pharmacotherapy 2011; 31:871-6
5. Eiland LS, English TM, Eiland EH. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother 2011; 45:582-9
6. Cano EL, Haque NZ,Welch VL, et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACTHAP database. Clin Ther 2012; 34:149-57
7. Hidayat LK, Hsu DI, Quist R, et al. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections. Arch Intern Med 2006; 166:2138-44
8. Pritchard L, Baker C, Legget J, et al. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Am J Med 2010; 123:1143-9
9. Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother 2011; 55: 5475-9
10. Jeffres MN, Isakow W, Doherty JA, et al. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther 2007; 29:1107-15
11. McKamy S, Hernandez E, Jahng M, et al. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr 2011; 158:422-6
12. Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007; 71:1028-35
13. Le J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J 2013; 32:e155-63
14. Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillinresistant staphylococcal infections. Pediatr Infect Dis J 2013; 32: 1077-9